Log In
Print
BCIQ
Print
Print this Print this
 

Actimmune, interferon gamma-1b

  Manage Alerts
Collapse Summary General Information
Company Horizon Pharma plc
DescriptionInterferon (IFN) gamma-1b
Molecular Target Interferon (IFN) gamma receptor
Mechanism of ActionInterferon gamma receptor (IFNGR) agonist
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$715.0M

$255.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today